Brief: Orexo Announces FDA Acceptance Of New Drug Application Filing For OX124

Orexo AB

28/11/2023 07:06

Nov 28 (Reuters) - Orexo AB  ORX.ST :
    * OREXO ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION
FILING
FOR OX124, A HIGH-DOSE RESCUE MEDICATION FOR OPIOID OVERDOSE
    * PRESCRIPTION DRUG USER FEE ACT DATE (PDUFA) SET TO JULY
15, 2024
    * IF APPROVED, US LAUNCH IS EXPECTED TO BE INITIATED LATE
2024

Source text for Eikon:  ID:nWkrtRfMX 
Further company coverage:  ORX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))